東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 2,778 | 2,778 | 2,730 | 2,773 | -3 | -0.1% | 94,800 |
| 2024/04/25 | 2,808 | 2,809 | 2,775 | 2,776 | -29 | -1% | 80,900 |
| 2024/04/24 | 2,807 | 2,825 | 2,780 | 2,805 | +10 | +0.4% | 93,000 |
| 2024/04/23 | 2,782 | 2,799 | 2,770 | 2,795 | +3 | +0.1% | 37,700 |
| 2024/04/22 | 2,769 | 2,813 | 2,769 | 2,792 | +42 | +1.5% | 65,800 |
| 2024/04/19 | 2,779 | 2,779 | 2,720 | 2,750 | -29 | -1% | 78,600 |
| 2024/04/18 | 2,751 | 2,795 | 2,751 | 2,779 | +28 | +1% | 49,900 |
| 2024/04/17 | 2,758 | 2,799 | 2,730 | 2,751 | -4 | -0.1% | 83,000 |
| 2024/04/16 | 2,755 | 2,768 | 2,735 | 2,755 | -28 | -1% | 84,500 |
| 2024/04/15 | 2,773 | 2,785 | 2,754 | 2,783 | -31 | -1.1% | 48,000 |
| 2024/04/12 | 2,771 | 2,824 | 2,771 | 2,814 | +43 | +1.6% | 87,400 |
| 2024/04/11 | 2,765 | 2,781 | 2,739 | 2,771 | -8 | -0.3% | 64,200 |
| 2024/04/10 | 2,773 | 2,793 | 2,762 | 2,779 | +9 | +0.3% | 48,400 |
| 2024/04/09 | 2,777 | 2,798 | 2,763 | 2,770 | -7 | -0.3% | 58,700 |
| 2024/04/08 | 2,786 | 2,786 | 2,751 | 2,777 | +32 | +1.2% | 83,700 |
| 2024/04/05 | 2,736 | 2,750 | 2,713 | 2,745 | -3 | -0.1% | 152,700 |
| 2024/04/04 | 2,757 | 2,764 | 2,712 | 2,748 | -9 | -0.3% | 118,100 |
| 2024/04/03 | 2,756 | 2,787 | 2,730 | 2,757 | +1 | ±0% | 155,900 |
| 2024/04/02 | 2,825 | 2,836 | 2,727 | 2,756 | -74 | -2.6% | 164,700 |
| 2024/04/01 | 2,908 | 2,908 | 2,830 | 2,830 | -74 | -2.5% | 99,500 |
| 2024/03/29 | 2,912 | 2,932 | 2,831 | 2,904 | -26 | -0.9% | 162,000 |
| 2024/03/28 | 2,955 | 2,973 | 2,926 | 2,930 | -66 | -2.2% | 123,200 |
| 2024/03/27 | 2,979 | 3,010 | 2,966 | 2,996 | +32 | +1.1% | 164,700 |
| 2024/03/26 | 2,900 | 2,987 | 2,899 | 2,964 | +54 | +1.9% | 165,600 |
| 2024/03/25 | 2,994 | 3,000 | 2,909 | 2,910 | -34 | -1.2% | 160,000 |
| 2024/03/22 | 2,975 | 3,015 | 2,927 | 2,944 | -34 | -1.1% | 166,200 |
| 2024/03/21 | 2,920 | 3,010 | 2,900 | 2,978 | +65 | +2.2% | 304,700 |
| 2024/03/19 | 2,858 | 2,934 | 2,842 | 2,913 | +55 | +1.9% | 188,100 |
| 2024/03/18 | 2,858 | 2,875 | 2,841 | 2,858 | +11 | +0.4% | 128,100 |
| 2024/03/15 | 2,840 | 2,856 | 2,822 | 2,847 | +3 | +0.1% | 137,300 |
| 2024/03/14 | 2,871 | 2,872 | 2,833 | 2,844 | -36 | -1.3% | 107,200 |
| 2024/03/13 | 2,875 | 2,886 | 2,832 | 2,880 | -24 | -0.8% | 154,200 |
| 2024/03/12 | 2,944 | 2,967 | 2,871 | 2,904 | +5 | +0.2% | 175,100 |
| 2024/03/11 | 2,898 | 2,956 | 2,870 | 2,899 | +41 | +1.4% | 218,400 |
| 2024/03/08 | 2,866 | 2,896 | 2,840 | 2,858 | +16 | +0.6% | 189,200 |
| 2024/03/07 | 2,828 | 2,896 | 2,811 | 2,842 | +59 | +2.1% | 203,300 |
| 2024/03/06 | 2,864 | 2,887 | 2,753 | 2,783 | -31 | -1.1% | 274,600 |
| 2024/03/05 | 2,726 | 2,912 | 2,691 | 2,814 | +64 | +2.3% | 513,300 |
| 2024/03/04 | 2,756 | 2,768 | 2,725 | 2,750 | -1 | ±0% | 155,300 |
| 2024/03/01 | 2,782 | 2,782 | 2,741 | 2,751 | -38 | -1.4% | 169,200 |
| 2024/02/29 | 2,777 | 2,834 | 2,777 | 2,789 | +8 | +0.3% | 195,400 |
| 2024/02/28 | 2,817 | 2,832 | 2,766 | 2,781 | -59 | -2.1% | 193,200 |
| 2024/02/27 | 2,870 | 2,893 | 2,833 | 2,840 | -53 | -1.8% | 194,800 |
| 2024/02/26 | 2,944 | 2,990 | 2,883 | 2,893 | -36 | -1.2% | 178,300 |
| 2024/02/22 | 3,010 | 3,015 | 2,901 | 2,929 | -70 | -2.3% | 205,400 |
| 2024/02/21 | 2,970 | 3,035 | 2,950 | 2,999 | -1 | ±0% | 188,400 |
| 2024/02/20 | 3,055 | 3,055 | 2,997 | 3,000 | -65 | -2.1% | 199,600 |
| 2024/02/19 | 2,980 | 3,075 | 2,980 | 3,065 | +102 | +3.4% | 169,400 |
| 2024/02/16 | 2,968 | 3,015 | 2,915 | 2,963 | +17 | +0.6% | 282,800 |
| 2024/02/15 | 3,230 | 3,240 | 2,917 | 2,946 | -249 | -7.8% | 501,000 |
1～
50
件表示中 / 6698件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 277,300円 | +9.6% | +279.3% | 2.16% | 10.50倍 | 0.93倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 住友ファーマ | 41,000円 | -42.9% | - | 0.00% | - | 0.40倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 科研薬 | 340,700円 | +0.2% | -8.3% | 4.40% | 19.26倍 | 0.92倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ネクセラファーマ | 145,800円 | +150.7% | - | 0.00% | 37.26倍 | 1.95倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ジーエヌアイ | 251,000円 | +52.1% | +23.3% | 0.00% | 17.74倍 | 3.70倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
